<DOC>
	<DOCNO>NCT01250730</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetics single dos PF-02341066 ( 150 , 250 , 400 mg ) fast condition Japanese healthy male volunteer .</brief_summary>
	<brief_title>A Study In Japanese Healthy Male Volunteers To Investigate The Safety , Tolerability And Pharmacokinetics Of PF-02341066</brief_title>
	<detailed_description>The purpose study investigate pharmacokinetics single dos PF-02341066 ( 150 , 250 , 400 mg ) fast condition Japanese healthy male volunteer .</detailed_description>
	<mesh_term>Crizotinib</mesh_term>
	<criteria>Healthy male subject , inclusive ( Healthy define clinically relevant abnormality identify detailed medical history , full physical examination , include blood pressure pulse rate measurement , 12lead ECG clinical laboratory test ) . Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg Subjects smoking , Subjects evidence disease , Subjects condition affect absorption , Subjects treatment investigational drug within 30 day , Subjects history regular alcohol consumption , Subjects use prescription , nonprescription drug dietary supplement within 28 day , Subjects blood donation approximately 400 mL within 3 month 200 mL within 1 month prior dose</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>PK profile Japanese healthy male volunteer</keyword>
</DOC>